ABT

Abbott Laboratories
Data: 2026-01-30
$109.3
Price
3.09%
Change
$141.23
52W High
$105.27
52W Low

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Quick Stats
Jan 30, 2026

62.5

AI Score

BUY

2.0

Volume Ratio

Apr 15, 2026

Next Earnings

9

+ve Days (30d)

21

-ve Days (30d)

ABT Stock Summary

Last updated Jan 30, 2026

ABT is currently trading at $109.3, positioned below its 200-day moving average of $129.15, suggesting bearish momentum. The stock has a 52-week range of $105.27 to $141.23.

Technical Analysis: The 50-day moving average stands at $122.96, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 29.725, suggesting the stock is oversold and potentially undervalued.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.136, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ABT at 62.5/100 with a BUY recommendation.

ABT (Abbott Laboratories) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 29.725
CMF (20) -0.136
ROC (10) -11.738
ADX (14) 30.951
Indicator Value
MACD (12,26,9) -4.913
AROONOSC (14) -85.714
WILLAMS %R (14) -82.376
MFI (14) 24.887
ABT Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ABT Price vs Max Options Open Interest
ABT Max Change In Options Open Interest

ABT Options - Sort by Max open Interest (near term)

30th January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABT Daily Out of Money Options - Sort by Max open Interest (near term)

30th January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABT Daily In the Money Options - Sort by Max open Interest (near term)

30th January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABT Most Active Options by Volume(near term)

30th January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Abbott Laboratories is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

ABT Moving Averages Analysis

ABT (Abbott Laboratories) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 111.82
20 118.66
30 120.86
50 122.96
100 126.65
200 129.15

ABT Fundamental Analysis

P/E (Forward) 19.0476
P/E (Trailing) 28.5081
Market Cap ($) 184.6 billion
Earnings/Share ($) 3.72
Net Proft Margin (%) 0.1472
Dividend/Share ($) 2.4
EPS Estimate Current Year ($) 5.6714
EPS Estimate Next Year ($) 6.2286
WallStreet Target Price ($) 136.3221
Most Recent Quarter